Nika Pharmaceuticals (NIKA) Net Income towards Common Stockholders (2021 - 2026)
Nika Pharmaceuticals' Net Income towards Common Stockholders was -$10,143 in Q3 2023, compared with -$6,339 a year earlier.
Powered by 
Analysis
Nika Pharmaceuticals (NIKA) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Nika Pharmaceuticals' Net Income towards Common Stockholders was -$72,569 through Sep 30, 2023; for FY2022, it was -$3.18 million.
- In earlier years, Net Income towards Common Stockholders was -$14,712 in FY2021.
- Quarterly Net Income towards Common Stockholders has moved between -$3.16 million (Q2 2022) and $5,754 (Q1 2021) over five years.
- Per Business Quant data, NIKA's Net Income towards Common Stockholders in the three quarters before Q3 2023 was -$27,806 (Q2 2023), -$19,570 (Q1 2023) and -$15,050 (Q4 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.24 Bn |
| 10 | Nika Pharmaceuticals | 369.14 Mn | 369.13 Mn | - | -13,023.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -13,023.00 |
| Jun 30, 2026 | -19,694.00 |
| Mar 31, 2026 | -13,359.00 |
| Dec 31, 2025 | -37,089.00 |
| Sep 30, 2025 | -7,982.00 |
| Jun 30, 2025 | -18,381.00 |
| Mar 31, 2025 | -12,945.00 |
| Dec 31, 2024 | -12,452.00 |
| Sep 30, 2024 | -8,367.00 |
| Jun 30, 2024 | -22,457.00 |
| Mar 31, 2024 | -65,988.00 |
| Dec 31, 2023 | -7,314.00 |
| Sep 30, 2023 | -10,143.00 |
| Jun 30, 2023 | -27,806.00 |
| Mar 31, 2023 | -19,570.00 |
| Dec 31, 2022 | -15,050.00 |
| Sep 30, 2022 | -6,339.00 |
| Jun 30, 2022 | -3.16 Mn |
| Mar 31, 2022 | -6,316.00 |
| Dec 31, 2021 | -26,124.00 |
API Access
Nika Pharmaceuticals Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=NIKA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "NIKA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=NIKA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();